CME Group is currently sporting a Zacks Rank of #2 (Buy). Over the past three months, the Zacks Consensus Estimate for CME's full-year earnings has moved 7.5% higher.

CME Group thrives on market volatility, earning revenue on every trade, making it resilient in both good and bad times. CME's niche in the derivatives market, international expansion, and product ...

CME Group Inc (NASDAQ:CME) recently announced a dividend of $1.15 per share, payable on 2024-03-26, with the ex-dividend date set for 2024-03-07. As investors look forward to this upcoming payment ...

CME Group Q2 2022 adjusted earnings per share is expected to be $1.97 per Trefis analysis, 2% above the consensus estimate of $1.93. The company’s adjusted net income in 2021 grew 24% y-o-y to ...

CME Group’s stock (NASDAQ: CME) has lost 9% YTD, while the S&P500 is down 18% over the same period. Further, its current price of $209 per share is trading 14% below its fair value of $243 ...

CME Group also operates one of the world's leading central counterparty clearing providers through CME Clearing, which offers clearing and settlement services across asset classes for exchange ...

CHICAGO, Sept. 11, 2018 /PRNewswire/ -- CME Group Inc. (NASDAQ: CME), the world's leading and most diverse derivatives marketplace, today filed its definitive proxy statement for a special meeting ...

CME Group Inc . CME has agreed to acquire NEX Group plc for £10 per share in a cash-stock deal. The transaction is expected to culminate in the second half of 2019, subject to closing conditions.

CME Group said the breach happened in July through the company's ClearPort system, a software platform where over-the-counter trading of commodities and currencies is reported.

The CME Coalition, a Washington, D.C.–based lobbying group that advocates for continuing medical education, recently launched a voluntary code of conduct for CME providers that addresses what it ...